2'-fluorothymidine has been researched along with fluorouracil in 1 studies
| Studies (2'-fluorothymidine) | Trials (2'-fluorothymidine) | Recent Studies (post-2010) (2'-fluorothymidine) | Studies (fluorouracil) | Trials (fluorouracil) | Recent Studies (post-2010) (fluorouracil) |
|---|---|---|---|---|---|
| 187 | 18 | 39 | 45,562 | 9,307 | 14,663 |
| Protein | Taxonomy | 2'-fluorothymidine (IC50) | fluorouracil (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.32 | |
| Thymidylate synthase | Mus musculus (house mouse) | 1.58 | |
| Aromatase | Homo sapiens (human) | 0.63 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, LW; Brown-Proctor, C; Collins, JM; Egorin, MJ; Eiseman, JL; Hamburger, DR; Joseph, E; Kinahan, PE; Klecker, RW; Mathis, CA; Pan, SS | 1 |
1 other study(ies) available for 2'-fluorothymidine and fluorouracil
| Article | Year |
|---|---|
Distribution of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) uracil in mice bearing colorectal cancer xenografts: rationale for therapeutic use and as a positron emission tomography probe for thymidylate synthase.
Topics: Animals; Arabinofuranosyluracil; Colorectal Neoplasms; DNA, Neoplasm; Female; Fluorouracil; HT29 Cells; Humans; Mice; Mice, SCID; Positron-Emission Tomography; Thymidylate Synthase; Time Factors; Tissue Distribution; Tritium; Xenograft Model Antitumor Assays | 2004 |